A 3D mini brain, created from human skin cells, will be used to study myelin. Read More
Artificial IntelligenceDeep LearningFeaturedMachine LearningNeurologyNeuroscienceOpen Neuroscience Articles
··6 min readCombining artificial intelligence technology with brain scan data, researchers have identified three novel subtypes of multiple sclerosis. Read More
Researchers shed new light on how remylination fails in multiple sclerosis. The study reports a drug, currently being studied as a cancer therapy, can alter the key signaling cascades that result in demylination associated with MS. Read More
Artificial IntelligenceDeep LearningFeaturedMachine LearningNeurologyNeuroscienceNeuroscience Videos
··4 min readCombing gait data from multiple sclerosis patients with machine learning, researchers have developed a new tool to monitor and predict disease progression. Read More
When injected with the new mRNA vaccine, mice with multiple sclerosis-like symptoms developed less severe symptoms than would normally occur. Read More
During anomalously warm weather, people with multiple sclerosis have a 4% increased risk of having an emergency department visit. 3% of MS patients had an increased risk of inpatient hospital stays. Read More
Contrary to popular belief, women with multiple sclerosis may not be at higher risk for complications during pregnancy, such as gestational diabetes or still-birth. However, babies of mothers with MS are more likely to be induced or believed by elective C-sections. Read More
IndCl, a drug that improves myelination and reduces motor disability, appears to improve visual problems associated with multiple sclerosis. Read More
Mice exposed to childhood stress were more likely to develop autoimmune disorders, like multiple sclerosis, and were less likely to respond to treatment. Read More
Immune cells in the meninges monitor fluid released from the brain. If the fluid contains signs of infection, disease, or damage, the immune cells initiate an immune response to tackle the problem. Read More
Gray matter damage associated with multiple sclerosis progression may be caused by inflammatory reactions that lead to synaptic loss. Read More
A newly discovered microbiome-controlled anti-inflammatory subset of astrocytes helps researchers better understand inflammation of the central nervous system and its regulation. Read More
